Objective: The objective of this study was to test our Viral Quinta Columna Strategy (VQCS), a new biological hypothesis predicting that specific multifunctional virally encoded cationic domains may have the capacity to penetrate human cells and interact with PP2A proteins to deregulate important human intracellular pathways, and may display LL37 cathelicidin-like antagonistic effects against multiple pathogens such as bacteria or viruses. Methods: We comparatively analyzed the host defense properties of adenodiaphorins and of some specific cationic sequences encoded by different viruses using two distinct biological models: U87G, a well-characterized cell tumor model; and a group B Streptococcus agalactiae NEM316 ΔdltA, highly sensitive to LL37 cathelicidin. [69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84] , and LL37 and LL 17-32 cathelicidin peptides also inhibited the survival of human U87G glioblastoma cells.
Introduction
Protein transduction domains (PTDs) and derived cell-penetrating peptides (cpps) are small peptide sequences derived from the few proteins that are naturally able to penetrate cells. [1] [2] [3] Furthermore, cpps usually contain short sequences with a positive charge resulting from several lysine and arginine residues, and are able both to deliver themselves and to deliver large micromolecules. 4 In addition, some cationic anti-microbial peptides (CAMPs), that have some similar physicochemical properties to cpps, can also have cell-penetrating properties, suggesting that they could be highly efficient therapeutic tools. 5, 6 CAMPs, such as the unique anti-microbial human cathelicidin LL37 peptide, are naturally produced by the innate immune system and mediate a widespread anti-microbial activity against Gram-positive and
Gram-negative bacteria such as Staphylococcus aureus and Escherichia coli, and also against fungi and enveloped viruses. 7, 8 Conversely, Gram-positive bacteria have evolved the ability to increase their positive surface charge through D-alanylation of teichoic acid, thus gaining resistance to CAMPs. 9 In addition, both LL37 and its C-terminal fragment LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] (also known as FK16) exhibit cytotoxicity against distinct tumor cells. 7, 10 The PP2A family of serine/threonine protein phosphatases, a major target for cationic sequences, is critically involved in the regulation of numerous intracellular pathways. 11 In addition, various viruses encode specific proteins that interact with PP2A holoenzymes to specifically deregulate the intracellular pathways of their hosts. 12 In this regard, two distinct small viral cationic proteins, HIV-1 Vpr and adenovirus type 2 (ad2) E4orf4, interact with a trimeric PP2A holoenzyme ABC, named PP2A 1 , to specifically induce p53-independent cell death. 13, 14 The C-terminus sequence of HIV-1 Vpr is a multifunctional domain with cell-penetrating, PP2A-mediated cell death and bactericidal anti-E. coli effects. 13, 15 Similarly to HIV-1 Vpr 77-92 , the ad2 E4orf4 64-95 (LadD 64-95 ) sequence contains residues required for PP2A binding, nuclear localization, and cell death. 14, 16 The Viral Quinta Columna Strategy (VQCS) is a new biological hypothesis that is based on combinatorial physical and biological properties, including cell penetration, PP2A interaction, and LL37-like host defense effects, that could be mediated by specific virally encoded cationic domains. 17 Consistent with this hypothesis, in this study we found that E4orf4 large adenodiaphorin (LadD 64-95 ) penetrating sequence, and cathelicidin active LL37 and LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] 
Quantification of peptide internalization
As previously described, 11 before incubation, the peptides were pre-incubated for 1 hour with streptavidin-HRP conjugate in a 4/1 ratio. Cells at 80% confluence were incubated with different concentrations of peptide in 24-well plates. After 6 hours, cells were washed twice in PBS, trypsinized (Trypsin EDTA; Invitrogen, Les Ulis, France), harvested in 1 mL of PBS, and counted. Cells were lysed in 300 μL of 0.1 M Tris (pH 7.4) and 0.5% Nonidet P-40 buffer for 10 minutes on ice. A total of 50 μL of cell lysate was mixed with 50 μL of OPD buffer (51.4 mM Na 2 HPO 4 and 24.3 mM citric acid), then mixed with 100 μL of OPD solution (one OPD tablet; Sigma) in 100 mL of OPD buffer to which 40 μL of 30% hydrogen peroxide was added just before use. After 10-20 minutes, the reaction was stopped by adding 100 μL of 1 M HCl, and optical density (OD) was read at 490 nm. The assays were performed in triplicate. We used Gen5 detection software (BioTek, Colmar, France) for data capture and export into Excel, and Microsoft Excel software 2016 for macOS for statistical analyses in histograms with error bars indicating the SD.
Cytotoxicity assays
As previously described, 11 3,000 cells were incubated for 24 hours with different concentrations of pharmacological agents. Cell cytotoxicity was analyzed by a colorimetric assay using MTT for adherent cells, as described by the manufacturer (Sigma).
The assays were performed in triplicate. We used Gen5 detection software (BioTek) for data capture and export into Excel. Histograms with error bars indicating the SD were created using Microsoft Excel software.
Bacterial strain and antibacterial susceptibility test
The S. agalactiae mutant NEM 316 ΔdltA strain, which is characterized by a complete absence of D-alanine due to the insertional inactivation of dltA, has been described previously. 18 The minimum inhibitory concentrations (MICs) of each peptide were tested in Todd-Hewitt broth (THB) buffered with 50 mM HEPES in 96-well Costar polypropylene microplates (Costar, Cambridge, MA, USA) by a dilution method. Bacteria (10 6 CFU) were added in triplicate to wells containing increasing concentrations of the anti-microbial peptides. Plates were incubated for 24 hours at 37°C and then read (OD 600 nm) using a microplate reader (Synergy 2; BioTek) for bacterial growth. The MIC 90 was considered to be the peptide concentration that inhibited 90% of growth.
Western blot analyses
As previously described, 11 exponentially growing cells (10 5 cells) were seeded overnight in 24-well culture cell plates, in a sub-confluent monolayer, prior to pharmacological treatments. For preparation of the extract, cells were rinsed in cold PBS, scraped, pelletized, and lysed in RIPA buffer 89900 supplemented with Halt Protease and Phosphatase Inhibitor Cocktail (78442; Thermo Scientific, Les Ulis, France), according to the manufacturer's instructions, and finally sonicated for 2 minutes at 50% pulse. The protein concentration in each sample extract was quantified using a Bio-Rad Protein Assay (Bio-Rad Laboratories, Les Ulis, France). Lanes were loaded with the material corresponding to 20-40 μg of cell protein extract. The following primary antibodies were used: anti-phospho-AKT (Ser 473) (D9E) and anti-AKT (pan) (C67E7) (Cell Signaling Technology, Saint-Cyr-l'École, France), and anti-HP1γ (2MOD-1G6) (Euromedex). Goat peroxidase-labeled anti-rabbit IgG or horse peroxidase-labeled anti-mouse IgG antibodies Figure 1, middle panel) . Finally, as illustrated in Figure 1 adD and RKKRRQRRR in HIV-1 Tat (single-letter amino acid code; basic residues are highlighted in bold type), displayed similar biological properties, such as cell penetration ( Figure 1 ) without toxicity ( Figure 2 ). In contrast, the larger adenodiaphorin LadD 64-95, containing the previously described PP2A binding sequence required for cell toxicity, 14 inhibited survival of U87G cells. Finally, as shown in Figure 1 (upper panel), we confirmed that the suppression of cationic properties resulting from the Internalized complexes were visualized by a colorimetric test, OPD, as described previously. 11,13 HRP internalization of E4orf4 peptides is expressed as % of Tat-mediated HRP peptide (incubated for 6 hours) used as positive control. SD is shown for n=3. For negative control (Control), no peptide, no HRP, HRP alone, or cargo-inactive DPT-sh1 peptide (VKKKIKREIKI) was used, giving similar results. 6.88±0.96 ng and 4.29±0.82 ng of HRP, respectively, were internalized by 105 U87G (upper and middle panels) and by 105 DHF (lower panel) cells following 6-hour incubation with 125 ng of biotinylated-Tat peptide complexed with streptavidin-peroxidase. Abbreviations: adD, adenodiaphorin; DHF, dermal human fibroblast; HRP, horseradish peroxidase; LadD, large adenodiaphorin; OPD, O-phenylenediamine dihydrochloride.
Comparative analyses of the effects of human cathelicidin LL37 and several virally encoded peptides on growth of Dalanylated mutants of human pathogen group B S. agalactiae and on the survival of human U87G glioblastoma cells
In addition to HIV-1 Tat cpp, the arginine/lysine-rich motif (RAKRRDRRRR) localized in LadD 64-95 is also partially homologous to virally encoded arginine/lysine-rich motifs deduced from HIV-1 Vpr, HIV-2 Tat, and JC polyomavirus small t proteins, suggesting that the derived viral sequences may display common properties. In this regard, as mentioned in the Introduction, these virally encoded cationic sequences have similar physical characteristics to the anti-microbial LL37 molecule, suggesting that these sequences may behave as cathelicidin-like host defense molecules. 17 Therefore, to test this hypothesis, we comparatively investigated the anti-microbial activities of these viral peptides with the two human LL-37 and LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] molecules by monitoring the bacterial growth of S. agalactiae NEM 316 ΔdltA strain, a Gram-positive bacterial model that is highly sensitive to human LL37 cathelicidin. 18 As shown in Table 3 (column 4), the MIC 90 values of LL37, HIV-1 Vpr, adenodiaphorins, and JC polyomavirus small t 115-134 lie in a similar range (12.5-25 μM). The C-terminal LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] fragment is more efficient than the full-length LL37 (MIC 90 12.5 μM and 6.25 μM, respectively). In addition, and surprisingly, HIV-2 Tat 67-90 is slightly more active than LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] (MIC 90 3.1 μM and 6.25 μM, respectively). As expected, no antibacterial activity was observed with Tat 47-57 cpp, used as a negative control. Notes: Amino acid residues are expressed in one-letter conventional code. Residues in red correspond to acidic residues (eg, D, E), residues in blue correspond to basic residues (eg, R, K, H), and residues in green correspond to hydrophobic uncharged residues (eg, F, I, L, M, V, W, A, P).°Charge density is calculated by dividing the net charge by the total number of amino acid residues (for detailed calculation see https:www.genescript.com/tools/peptide-properties-calculator). *The minimum inhibitory concentration (MIC; μM) of each peptide is an average of triplicate measurements performed by a dilution method in 96-well polypropylene microplates. The MIC 90 was considered to be the peptide concentration that inhibited growth of 90% of the tested strains.
We also comparatively investigated the effect of human cathelicidin LL37 and virally encoded cationic peptides on survival of human U87G glioblastoma cells. We performed the MTT assay to monitor cytotoxicity of full-length LL-37 and C-terminal LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] , also named FK16, 21 peptides in the U87G glioblastoma cell line. As shown in Figure 3 (upper panel), consistent with the previously described toxic effect in colon cancer cells, 21 both LL37 and LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] peptides provoke a similar and important reduction in the viability of U87G cells in a dose-dependent manner. Furthermore, as illustrated in Figure 3 (lower panel), we observed a dose-dependent reduction in U87G cell viability with adD 67-84 and adD 69-84 , but not adD 69-83 (F84 deleted mutant). In addition, no significant toxicity was observed with HIV-2 Tat 67-90 and JC polyomavirus small t 115-134 treatments.
Discussion
The VQCS model predicts that multifunctional specific virally encoded cationic sequences may have the capacity to penetrate cells and to deregulate important human intracellular signaling pathways, such as PP2A-mediated pathways, but may also display LL37 cathelocidin-like antagonistic effects against multiple pathogens such as bacteria or viruses. 17 In this study, following the identification of ad2 E4orf4 cationic penetrating sequences, named adenodiaphorins, we tested the VQCS hypothesis by comparatively analyzing host defense properties of adenodiaphorins and some specific cationic sequences encoded by different viruses using two distinct biological models: U87G, a wellcharacterized cell tumor model; and a group B S. agalactiae NEM316 ΔdltA highly sensitive to LL37 cathelicidin.
Host defense properties of adenovirus E4orf4 adenodiaphorin penetrating sequences
Adenoviruses are non-enveloped double-stranded DNA viruses that can infect human tissues to provoke mild gastrointestinal and respiratory symptoms, and are often associated with pediatric patients. 22 The common species C adenoviruses (serotypes Ad1, Ad2, Ad5, and Ad6) infect more than 80% of the human population early in life and they also form latent infections in human lymphocytes. 23 In this study, we found that the full-length Ad2 E4orf4 sequence is a new cell-penetrating polypeptide and we demonstrated that the E4orf4 64-95 /LadD 64-95 sequence, previously characterized as a multifunctional PP2A-binding domain and as a PP2A-dependent death sequence, is also a new PTD. In addition, we analyzed the potential host defense properties of the anti-microbial LL-37 and LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] cathelicidin peptides with specific virally encoded cationic peptides, including E4orf4 adenodiaphorin sequences, against both glioblastoma cells and S. agalactiae NEM 316 ΔdltA strain. Using U87G glioblastoma cells, we demonstrated that LL-37, the only cathelicidin found in humans, and its shorter active fragment LL [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] , are potent inhibitors of U87G glioblastoma cell survival. It has been reported that LL37 can mediate a dual role in tumorigenesis. First, as a positive factor, LL37 can promote the growth of ovarian, 24 lung, 25 and breast cancers. 26 Second, LL37 can promote tumor suppression in gastric cancer, 27 acute myeloid leukemia, 28 and lymphocytic leukemia. 29 Since U87G is HIV-1 Vpr, be liberated after the lysing of infected cells and circulate in biological fluids. Together, in agreement with the potential infective effects predicted by the VQCS hypothesis, our results suggest that the presence of virally encoded cationic peptides, such as adenodiaphorins and HIV-1 Vpr peptides, which could circulate in biological fluids, may define a new paradigm for a potential virally mediated innate immunity. In addition, it is noteworthy that anti-biofilm effects and wound-healing properties of LL-37 have already been shown, suggesting that LL37, or its derivatives, could be used to develop new therapeutic strategies against biofilm-mediated infections to treat polymicrobially infected wounds through topical application. 38, 39 Since the results in Table 3 clearly indicate that viral peptides work in the same LL37 concentration range, in accordance with the VQCS hypothesis, 17 we can postulate that some peptides containing virally encoded sequences may behave as LL37 derivatives and may be used against infected wounds.
Our results represent the first experimental data consistent with the VQCS hypothesis. Furthermore, in conjunction with future work involving other viruses, microbes, and parasites, the mimicry of host defense peptides of viral origin may represent a promising approach to design new therapeutic molecules with anti-infective and antitumor effects, as previously suggested with cellular host defense sequences. 40 
